Corporate Banner
Satellite Banner
Environmental Analysis
Scientific Community
Become a Member | Sign in
Home>News>This Article

Rapid Micro Biosystems Secures $32.6 Million in Series B Financing

Published: Thursday, June 27, 2013
Last Updated: Thursday, June 27, 2013
Bookmark and Share
Longitude Capital and TPG Biotech lead investment with participation from existing investors.

Rapid Micro Biosystems announced that it has raised $32.6 million in series B financing. The funding will be used to expand the commercial and manufacturing operations in support of the Growth DirectTM System and the companion applications including: environmental monitoring, sterility and bioburden testing. Providing faster results from quality control testing allows drugs to be produced and released more quickly, economically and safely.

Longitude Capital and TPG Biotech led this financing round with continued participation from Kleiner Perkins Caufield & Byers, TVM Capital and Quaker Partners. Dr. Mark Braganza, Principal at TPG Biotech and Dr. David Hirsch, Managing Director at Longitude Capital will be joining the Rapid Micro Biosystems’ board of directors.

“We are excited to be part of a company that offers such a compelling value proposition—both in automation and testing speed—to pharmaceutical, biotech and personal care product companies,” said Dr. Braganza.

“The Growth DirectTM system offers an innovative approach to microbial detection and enumeration, allowing quality control microbiologists to focus on higher value activities,” said Dr. Hirsch. “We are pleased to play a role in their expansion.”

The Growth DirectTM is the only system on the market where all the applications can be run both concurrently and automatically on a single instrument. The system provides results starting within just hours; sending problem alerts so that decision-making and remedial action can start immediately. Leveraging an already proven detection technology, the Growth DirectTM delivers exceptional enhancements to productivity, faster response time and reduction in errors.

“These unique capabilities provide an attractive return on investment for our customers and getting drugs to market faster ultimately benefits patients,” said Steve Delity, President and CEO. “Our new investment partners, along with our current investors, position Rapid Micro Biosystems to meet the customer requirements for automated microbial detection and enumeration.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Safer, Faster Way To Remove Pollutants From Water
Using nanoparticles filled with enzymes proves more effective than current methods.
Low Impact Fracking Fluid on Top at IChemE Global Awards
A novel fracturing fluid designed to make fracking greener.
Marine Invasive Species May Benefit From Rising CO2 Levels
Ocean acidification may well be helping invasive species of algae, jellyfish, crabs and shellfish to move to new areas of the planet with damaging consequences, according to the findings of a new report.
Game for Climate Adaptation
MIT-led project shows a new method to help communities manage climate risks.
Tufts Chemist Discovers Way to Isolate Single-crystal Ice Surfaces
Promises insights into climate, environment and age-old riddles, such as why no two snowflakes are alike.
Potential Indirect Effects of Humans on Water Quality
Newly studied class of water contaminants occur naturally, but are more prevalent in populated areas.
Rapid Method for Water, Air and Soil Pathogen Screening
Researchers at BGU and the Massachusetts Institute of Technology (MIT) have developed a highly sensitive, cost-effective technology for rapid bacterial pathogen screening of air, soil, water, and agricultural produce in as little as 24 hours.
First Results Describing Sick Sea Star Immune Response
Though millions of sea stars along the West Coast have perished in the past several years from an apparent wasting disease, scientists still don’t know why.
Microbe Sleuth
Tanja Bosak examines how life and the Earth evolved in tandem during their early history together.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos